A Behavioral Intervention to Reduce Sexual Risk Among African-American Men Who Have Sex With Men

This study is currently recruiting participants.

Verified by Centers for Disease Control and Prevention, July 2008

Sponsors and Collaborators:	New York Blood Center Centers for Disease Control and Prevention The New York Academy of Medicine
Information provided by:	Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:	NCT00691496

Purpose

The purpose of this project is to test the efficacy of an HIV prevention behavioral intervention to reduce sexual risk among African-American men who have sex with men (MSM).

Condition	Intervention
HIV Infections	Behavioral: Behavioral intervention to reduce sexual risk among African-American men who have sex with men

MedlinePlus related topics: AIDS

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title:	A Behavioral Intervention to Reduce Sexual Risk Among African-American Men Who Have Sex With Men

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:

The primary goal of the intervention is to reduce HIV transmission or acquisition by reducing the frequency of unprotected anal intercourse among African-American MSM. [ Time Frame: 3 months after completing intervention ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Encourage participants to engage in discussions to reduce sexual risk within their social network and with sexual partners. [ Time Frame: 3 months after completing the intervention ] [ Designated as safety issue: No ]

Estimated Enrollment:	300
Study Start Date:	May 2008
Estimated Study Completion Date:	September 2009
Estimated Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
1: Experimental Receives HIV testing and counseling and 5 week intervention	Behavioral: Behavioral intervention to reduce sexual risk among African-American men who have sex with men 5 week intervention to increase skill level of participants with talking to their social networks and sexual partners about reducing high risk sexual behaviors while preparing a healthy meal
2: No Intervention Receives only HIV Testing and Counseling

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria: identify as African-American, Black, Caribbean Black or multiethnic Black, report sex with men

Exclusion Criteria:

Participated in pilot
Identify as transgender
Plan to move before end of study
Refuse HIV testing at baseline or identified as a newly diagnosed HIV through testing at the baseline
Under 18 years of age

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00691496

Contacts

Contact: Krista Goodman

212-388-0008

kgoodman@nybloodcenter.org

Locations

United States, New York
New York Blood Center	Recruiting
New York, New York, United States, 10003
Contact: Beryl Koblin, PhD 212-570-3105 BKoblin@NYBloodCenter.org
Principal Investigator: Beryl Koblin, PhD

Sponsors and Collaborators

New York Blood Center

Centers for Disease Control and Prevention

The New York Academy of Medicine

Investigators

Principal Investigator:

Beryl Koblin, PhD

New York Blood Center

More Information

Responsible Party:	New York Blood Center ( Beryl Koblin, PhD )
Study ID Numbers:	CDC-NCHHSTP-5157
Study First Received:	June 3, 2008
Last Updated:	July 7, 2008
ClinicalTrials.gov Identifier:	NCT00691496
Health Authority:	United States: Federal Government; United States: Institutional Review Board

Keywords provided by Centers for Disease Control and Prevention:

HIV Prevention
African-American
gay

bisexual
intervention trial
HIV Seronegativity

Study placed in the following topic categories:

Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases

Acquired Immunodeficiency Syndrome
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:

RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
Lentivirus Infections
Infection

ClinicalTrials.gov processed this record on January 15, 2009